Prohibitin accumulation in mitochondria and de novo accumulation has been shown to cause chemoresistance, while knock-down of prohibitin sensitized cancer cells to chemotherapeutic treatment (Tortelli et al., 2017). This evidence concerns the gene PHB1 and cancer.